TAGRISSO 80 mg film-coated tablets
Approved small_molecule active
Quick answer
TAGRISSO 80 mg film-coated tablets for Patients with EGFR mutant NSCLC according to TP53 mutational status is a Approved program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- Patients with EGFR mutant NSCLC according to TP53 mutational status
- Phase
- Approved
- Modality
- small_molecule
- Status
- active